TAIEquity · Weekly research terminal

1733

Apex Biotechnology Corp.

TW Healthcare Biotechnology

Latest week
7 Aug 2026
Weekly close
32.00 TWD
Fair value
28.51 TWD
Next-week expectancy
Undecided 48.33%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

1733

Apex Biotechnology Corp.

Healthcare Biotechnology

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing systems. The company also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
3,078,465,792
Fair value reference
28.51
Next-week expectancy
Undecided · 48.33%

Over the latest 12 completed weeks ending 2026-08-07, 1733 rose 12.83%, moving from 28.36 to 32.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 5 of the last 12 weeks. Relative Strength is -21.79 and has improved across the 12-week window. Market Dynamics is 1.62 on the latest week. Next-week expectancy is undecided at 48.33% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
32.00
12-Week Change
12.83%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.33%
Signal Weeks
5 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
32.00
12-Week Change
12.83%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.33%
Signal Weeks
5 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-21.79
Market Dynamics
1.62

Over the latest 12 completed weeks ending 2026-08-07, 1733 rose 12.83%, moving from 28.36 to 32.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 5 of the last 12 weeks. Relative Strength is -21.79 and has improved across the 12-week window. Market Dynamics is 1.62 on the latest week. Next-week expectancy is undecided at 48.33% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6949 Pell Bio-Med Technology Co., Ltd. TAI 7 Aug 2026 800.00 999.00 799.00 943.00 17.88%
1762 Chunghwa Chemical Synthesis & Biotech Co., Ltd. TAI 7 Aug 2026 32.20 35.75 31.60 35.75 11.02%
6589 EirGenix Inc. TAI 7 Aug 2026 44.60 48.90 44.30 48.20 8.07%
7827 HanchorBio Inc. TAI 7 Aug 2026 144.50 157.50 144.50 156.00 7.96%
4142 Adimmune Corporation TAI 7 Aug 2026 16.55 17.80 16.45 17.70 6.95%
4178 StemCyte International, Ltd. TAI 7 Aug 2026 17.40 19.00 17.40 18.40 5.75%
6919 CALIWAY BIOPHARMACEUTICALS CO L TAI 7 Aug 2026 102.00 111.00 102.00 105.00 2.94%
6541 Tanvex BioPharma, Inc. TAI 7 Aug 2026 37.10 38.45 36.60 38.05 2.56%
6657 Energenesis Biomedical CO.,LTD. TAI 7 Aug 2026 30.50 31.55 29.40 31.20 2.30%
4133 Abnova (Taiwan) Corporation TAI 7 Aug 2026 20.75 21.85 20.75 21.20 2.17%
3164 GenMont Biotech Incorporation TAI 7 Aug 2026 16.25 16.60 16.00 16.40 0.92%
6885 BRIM Biotechnology, Inc. TAI 7 Aug 2026 20.95 21.20 20.50 21.10 0.72%
6550 Polaris Group TAI 7 Aug 2026 11.05 11.35 10.90 11.10 0.45%
1734 Sinphar Pharmaceutical Co.,Ltd. TAI 7 Aug 2026 31.70 31.80 31.30 31.80 0.32%
4169 TCM Biotech International Corp. TAI 7 Aug 2026 158.00 167.50 153.00 157.00 -0.63%
6838 Formosa Pharmaceuticals, Inc. TAI 7 Aug 2026 23.40 23.75 22.80 23.20 -0.85%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context